Sign in to follow
Search Results

0 results for ''McDonnell Boehnen Hulbert''

You can use to get even better search results
October 23, 2020 | The American Lawyer

Hire Up: Are Real Estate Practices Readying for a Comeback?

The lateral market saw some rare real estate movement this week, while firms continued to add government, IP and cybersecurity lawyers.
4 minute read
May 06, 2020 | The American Lawyer

He's Been Everywhere, Man: IP Boutique Partner Allegedly Faked Trips to 43 Cities and Charged His Firm

A former partner at Chicago's McDonnell Boehnen Hulbert & Berghoff is accused of submitting nearly 400 false expense claims, demanding more than $360,000 from the firm for bogus trips across a broad swath of North America.
3 minute read
December 24, 2019 | The American Lawyer

Law Firm Expansion in Texas Continued at Strong Clip in 2019

Out-of-state firms continued to open new offices in Texas cities in 2019, a trend that accelerated in 2017 and hasn't slowed.
4 minute read
July 14, 2015 | The American Lawyer

Hausfeld Rides Big Fees Into New York, Plus More Lateral Moves

High-powered plaintiffs shop Hausfeld hires two antitrust litigators from Greenberg Traurig to open in the Big Apple; Greenberg Traurig opens its first office in Germany; Pillsbury picks up two; and other notable additions from throughout The Am Law 200.
8 minute read
March 27, 2012 | The American Lawyer

No Professional Courtesy Here

4 minute read
August 21, 2012 | The American Lawyer

The Churn: Lateral Moves and Promotions in the Am Law 200

Littler Mendelson announces new co-presidents starting in January; Dickinson Wright recruits a group of five health care lawyers in Michigan; and Gardere Wynne Sewell hires a government regulation expert from the Department of Energy. The Churn is constant. Please send all announcements to [email protected].
4 minute read
Sanofi, Albany Molecular Win Preliminary Injunction Blocking Dr. Reddy's Generic Version of Allegra
Publication Date: 2010-06-15
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

At risk drug launches, in which a generic manufacturer launches its version of a brand-name drug without a finding that the brand manufacturer's patent is invalid or not infringed, amount to a high-stakes game of chicken by the generic. They're rarely attempted--and the fate of Dr. Reddy's version of Allegra-D shows why.

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • The Future of AI in Law

      Brought to you by Filevine

      Download Now